Euromedis Groupe SA represents a set of core values and corporate philosophy that guide its operations. With a strong commitment to quality and innovation, the company strives to provide exceptional healthcare solutions to its customers. Euromedis Groupe SA prioritizes integrity, fostering trust and transparency in all business dealings. By emphasizing customer satisfaction, the company aims to deliver excellent products and services that meet the evolving needs of the healthcare industry. Euromedis Groupe SA's dedication to collaborative partnerships and continuous improvement enables it to contribute to the advancement of medical technology and patient care.

Euromedis Groupe SA is primarily present in France and other European countries.

Euromedis Groupe SA, a renowned company, has achieved numerous significant milestones. Over the years, Euromedis Groupe SA has successfully expanded its operations, establishing a strong global presence. The company has consistently delivered innovative solutions in the medical and healthcare industry, earning it a notable reputation. Euromedis Groupe SA has achieved remarkable financial growth, attracting investments and shareholders' trust. It has also garnered recognition for its superior product quality, cutting-edge research and development, and commitment to customer satisfaction. Furthermore, Euromedis Groupe SA has formed strategic partnerships with key industry players, further enhancing its market position. Overall, Euromedis Groupe SA's impressive achievements make it a leading force in the stock market.

Euromedis Groupe SA is a leading medical technology company with a rich history and solid background. Established in 1998, the company has been dedicated to developing innovative healthcare solutions that enhance patient care. Euromedis Groupe SA focuses on designing and manufacturing high-quality medical devices that cater to various medical fields including sterilization, infection control, and surgical instruments. With a strong commitment to research and development, the company has consistently introduced cutting-edge products that address the evolving needs of the medical industry. Euromedis Groupe SA's dedication to excellence and customer satisfaction has allowed it to establish a reliable reputation within the healthcare sector.

The main competitors of Euromedis Groupe SA in the market include Medtronic Inc., Johnson & Johnson, and Stryker Corporation.

Euromedis Groupe SA is primarily active in the pharmaceutical and healthcare industries.

Euromedis Groupe SA has a diversified business model that encompasses various activities in the healthcare sector. The company operates as a distributor and retailer of medical supplies, equipment, and pharmaceutical products. Additionally, Euromedis Groupe SA offers a range of healthcare services such as logistics and supply chain management, clinical support, and specialized training. The company aims to provide comprehensive solutions to healthcare professionals, hospitals, clinics, and pharmacies. By leveraging its extensive network and expertise, Euromedis Groupe SA strives to meet the evolving needs of the healthcare industry and contribute to the improvement of patient care.

Laboratoires Euromedis KGV ir 13,00.

Laboratoires Euromedis KUV ir 0,23.

AlleAktien kvalitātes vērtējums Laboratoires Euromedis ir 3/10.

gaidāmā Laboratoires Euromedis apgrozījums ir 64,68 milj. EUR.

gaidāmā Laboratoires Euromedis peļņa ir 1,15 milj. EUR.

Euromedis Groupe SA is an internationally active company specializing in the distribution of medical products and equipment. The company's business model is based on a combination of distributing medical devices and consumables, as well as providing services related to medical care. The company is divided into several business areas to meet the needs of customers. The main divisions include the distribution of medical devices, the sale of consumables, the management of medical facilities, and consulting in healthcare. In the field of medical devices, Euromedis Groupe SA offers a wide portfolio of products ranging from simple instruments to complex medical devices. These products include endoscopy systems, ultrasound and X-ray systems, anesthesia and ventilation devices, as well as EKG monitors and surgical instruments. In addition, Euromedis Groupe SA also offers a wide range of consumables needed for medical purposes. These include products such as wound dressings, infusion solutions, surgical clothing, gloves, and syringes. An important business area of Euromedis Groupe SA is the management of medical facilities. The company provides qualified support in the management of medical facilities, including services such as project planning and coordination, medical consultation, training and education of medical personnel, as well as management and operation of medical facilities. Consulting in healthcare is another important business area of Euromedis Groupe SA. The company offers consulting services that include planning, implementation, and monitoring of medical projects and programs. The company particularly focuses on the needs of healthcare providers and government agencies. Overall, the business model of Euromedis Groupe SA is based on a combination of high-quality medical products and comprehensive services in healthcare. The company relies on highly qualified employees and places great importance on customer satisfaction and service quality. As an internationally active company, Euromedis Groupe SA is successfully positioned in the market and is considered a reliable and competent partner in the field of medical care. Thanks to its focus on quality and customer satisfaction, the company has built a stable customer base and has been able to maintain its position in the market in the long term.

Laboratoires Euromedis izmaksā dividendes 0 EUR, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt Laboratoires Euromedis vai uzņēmums nedod dividendes.

Laboratoires Euromedis ISIN ir FR0000075343.

Laboratoires Euromedis WKN ir 806302.

Laboratoires Euromedis simbols ir ALEMG.PA.

Pēdējo 12 mēnešu laikā Laboratoires Euromedis maksāja dividendes 0,09 EUR apmērā. Tas atbilst aptuveni 1,72 % dividendes ražībai. Nākamajos 12 mēnešos Laboratoires Euromedis plāno maksāt dividendes 0 EUR apmērā.

Laboratoires Euromedis pašreizējā dividendu rentabilitāte ir 1,72 %.

Laboratoires Euromedis maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos marts, marts, marts, februāris.

Laboratoires Euromedis pēdējo 2 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 EUR. Tas atbilst dividendes ražībai 0 %.

Laboratoires Euromedis tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Laboratoires Euromedis apmērā 0,09 EUR, kas tika izmaksāta 2.02.2017., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 31.01.2017..

Pēdējās dividendes izmaksa notika 2.02.2017..

Gadā 2023, Laboratoires Euromedis izmaksāja 0 EUR dividendes.

Laboratoires Euromedis dividendes tiek izmaksātas EUR.